Drug recall · June 10, 2026
Niacin Extended-release Tablets recall
Why: Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
- Lots / codes
Lot #: 25282724A, Exp. Date 2027/01
- Quantity
- 3984 bottles
- Company
- Lannett Company Inc., Seymour, IN
- Distribution
- Nationwide within the United States
- Initiated
- May 27, 2026 · Voluntary: Firm initiated
- Classified
- June 10, 2026
- Reported
- June 10, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Niacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.